Document Detail

Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
MedLine Citation:
PMID:  19730097     Owner:  NLM     Status:  In-Data-Review    
PURPOSE: : To compare the efficacy of topical cyclosporine 0.05% (tCsA) and combined treatment with 1% methylprednisolone acetate for the treatment of moderate-to-severe chronic dry eye.
PATIENTS AND METHODS: : Forty-four patients with moderate-to-severe dry eye who had not responded to conventional treatment were treated with tCsA for 3 months. Twenty-one subjects (Group 1) were treated with 1% methyl prednisolone acetate and tCsA for the initial 3 weeks, and treated with tCsA only thereafter, and 23 subjects (Group 2) were treated with tCsA only. Symptom scores, tear break-up time (TBUT), Schirmer score, and corneal and conjunctival fluorescein staining were evaluated before and at 1, 2, and 3 months after treatment. Proinflammatory factors, interleukin-6 (IL-6), and interleukin-8 (IL-8) tear concentration were measured before treatment and at 3 months.
RESULTS: : Symptom scores, Schirmer scores, TBUT score, corneal fluorescein, and conjunctival staining showed significant improvement at 1 month compared to baseline in group 1 (all P < 0.001), and all the same but few exceptions in group 2 (P = 0.002 on Schirmer, P = 0.267 on cornea stating). In symptom scores, Schirmer scores, and corneal staining, greater improvements were observed for group 1 at 1 month compared to group 2 (P < 0.001, P = 0.039, P = 0.01, respectively). However, in TBUT score and conjunctival staining, there were no between-group differences (P = 0.277, P = 0.254, respectively). The time interval from treatment initiation to symptom relief was shorter for group 1 than group 2. Both groups showed decreased tear IL-6 and IL-8 concentrations at 3 months compared to baseline levels (P < 0.05). However, no between-group differences were noted in mean concentrations of IL-6 and IL-8 at baseline and at 3 months.
CONCLUSIONS: : Treatment with tCsA appears to be safe and effective in moderate-to-severe chronic dry eye. Additional short-term use of a topical steroid had the benefit of providing faster symptom relief and improvement of ocular sign without serious complications.
Yeo-Jue Byun; Tae-Im Kim; Sang Min Kwon; Kyung Yul Seo; Sun Woong Kim; Eung Kweon Kim; Woo Chan Park
Related Documents :
24998087 - Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatra...
15177957 - Artisan toric lens implantation for correction of postkeratoplasty astigmatism.
479007 - Primary vs. secondary insertion of anterior chamber lenses.
8524557 - Contact lens fitting after photorefractive keratectomy: a comparison of two groups of p...
15952487 - A patient with abdominal distension.
21872527 - Evolution in the techniques and outcomes of aortic arch surgery: a 22 year single centr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cornea     Volume:  31     ISSN:  1536-4798     ISO Abbreviation:  Cornea     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-04-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8216186     Medline TA:  Cornea     Country:  United States    
Other Details:
Languages:  eng     Pagination:  509-13     Citation Subset:  IM    
*Vision Research Institute, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea †Department of Ophthalmology, Dong-A University College of Medicine, Busan, Korea ‡Department of Ophthalmology, Soonchunhayng University College of Medicine, Bucheon, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pythium insidiosum keratitis in contact lens wear: a case report.
Next Document:  Transfusion therapy in hemorrhagic shock.